A well-known veterinary drug brand, a listed company, and a high-tech enterprise integrating the research and development of veterinary biological products, chemical raw materials, high-tech preparations, and the modernization of traditional Chinese medicine
Pleco Bioengineering Co., Ltd. is a high-tech enterprise mainly engaged in R&D, production and operation of veterinary biological products (vaccines and diagnostic reagent products) and drugs, with Luoyang Huizhong Veterinary Drug Co., Ltd., Luoyang Huizhong Biotechnology Co., Ltd., Henan Xinzheng Bioengineering Co., Ltd., Luoyang Zhongke Science and Technology Park Co., Ltd. 4 wholly-owned subsidiaries and Luoyang Pleco Wantai Biotechnology Co., Ltd. and other 2 joint-stock companies, the company has always adhered to the development strategy of leading the enterprise to leapfrog development and transformation and upgrading with scientific and technological innovation The company's comprehensive strength ranks in the forefront of the industry; In 2006, it was awarded the title of "Leading Enterprise of Animal Husbandry and Veterinary Science and Technology Innovation in China"; In 2008, 2011 and 2014, it was continuously recognized as a "new standard high-tech enterprise", and was an innovative pilot enterprise, a key transformation and upgrading enterprise of 100 enterprises and a high-growth private enterprise supported by the Henan Provincial Government. In 2010, the company was recognized as "Key High-tech Enterprise of the National Torch Program" by the Ministry of Science and Technology; In 2015, it was awarded the "National Technology Innovation Demonstration Enterprise"; In 2016, it was recognized as "Henan Province Innovation Leading Enterprise".
In 2008, the company was approved by the Ministry of Human Resources and Social Security of the People's Republic of China to set up a postdoctoral research workstation, in 2010 by the Provincial Department of Science and Technology approved the establishment of a veterinary drug development academician workstation, in 2009 by the Ministry of Science and Technology approved the establishment of the National Veterinary Drug Engineering Technology Research Center. The center is the first national engineering technology research center approved by enterprises in the field of biopharmaceuticals in Henan Province and the veterinary drug industry in China, and will also become the commanding heights of the technology platform of China's veterinary drug industry and the support point of the regional industrial development and innovation platform. The center consists of seven research institutes of animal vaccines, diagnostic reagents, bioengineering, process technology, high-tech preparations, chemical drug synthesis, and traditional Chinese veterinary drugs and a complete supporting system. It has the strength to carry out systematic, supporting and engineering research and development of major critical, basic and common industrial technologies. In 2012, the company's technology research and development center was once again recognized as a national enterprise technology center by the National Development and Reform Commission, the Ministry of Science and Technology and other five ministries and commissions. In 2015, the National Development and Reform Commission approved the establishment of a national and local joint engineering laboratory for the development of diagnostic reagents and vaccines for animal infectious diseases. So far, the company has three national R&D institutions.
Relying on the technology research and development center and the implementation of major national science and technology projects and high-tech industrialization projects, the company has achieved a major breakthrough in technological innovation and product research and development, up to now, a total of 31 national new veterinary drugs issued by the Ministry of Agriculture, 4 national key new products have been successfully developed, and nearly 400 national invention patents have been applied, including more than 120 national invention patents, 1 has won the China Patent Excellence Award, established 53 national standards, and won major national and There are more than 10 provincial and municipal scientific and technological achievement awards, leading the industry direction of domestic veterinary drug technology innovation and product research and development, and making practical contributions to the prevention and control of major epidemics in animal husbandry. The company leads the development of enterprises with scientific and technological innovation, and feeds back the good interactive pattern of scientific and technological innovation with good economic benefits, which supports the enterprise to embark on the road of sustainable, healthy and rapid development, and at the same time brings huge economic and social benefits to the industry.
Pleco adheres to the tenet of "gold medal quality, benefiting mankind", pursues the development concept of "innovation achieves the future", adheres to the development strategy of "decent and steady operation", carries forward the enterprise spirit of "integrity and pragmatism, courage to create first-class", engages in the research, production and promotion of new veterinary vaccines and new veterinary drugs with a high starting point and high standards, and is committed to building a world brand in China's animal health products industry!
